Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

Director/PDMR Shareholding

10 Aug 2011 07:00

RNS Number : 0554M
Gresham Computing PLC
10 August 2011
 

Gresham Computing plc

 

Director's Dealings

 

Gresham Computing plc (the "Company") has received notification that on 9 August 2011, Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), acquired 100,000 ordinary shares in the Company at a price of 46.65 pence per share and acquired 50,000 ordinary shares in the Company at a price of 45.00 pence per share.

 

Kestrel Partners LLP, which Max Royde (Non-executive Director of the Company) is a partner of and holds a beneficial interest in, is the investment manager to Kestrel Opportunities. Mr Royde is also a shareholder in Kestrel Opportunities.

 

Kestrel Opportunities holds 3,627,854 ordinary shares in the Company, which represents approximately 6.2 per cent of the Company's issued share capital.

 

-ends-

 

For further information please contact:

Gresham Computing plcChris Errington, CEOKen Archer, ChairmanRob Grubb, CFO

+44 (0) 20 7653 0200

Singer Capital Markets LtdShaun Dobson, Partner and Joint Head of Corporate FinanceJames Maxwell, Director of Corporate Finance

+44 (0) 20 3205 7500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSUFIUFFSEIA
Date   Source Headline
10th Jan 201811:57 amRNSHolding(s) in Company
9th Jan 20187:00 amRNSTrading Update
29th Dec 20179:52 amRNSSignificant CTC banking contract win in Europe
11th Dec 20174:12 pmRNSResult of General Meeting
22nd Nov 20177:00 amRNSProposed Share Bonus Plan and Notice of GM
4th Oct 20177:00 amRNSTrading Update
22nd Sep 201710:05 amRNSHolding(s) in Company
21st Sep 20172:32 pmRNSHolding(s) in Company
13th Sep 20177:00 amRNSExercise of Options
5th Sep 20177:00 amRNSDirectorate Change
30th Aug 20174:43 pmRNSHolding(s) in Company
29th Aug 20177:00 amRNSNorth American Tier 1 bank win for CTC
22nd Aug 20173:30 pmRNSHolding(s) in Company
27th Jul 20175:05 pmRNSHolding(s) in Company
25th Jul 20177:00 amRNSHalf-year Report
7th Jul 20177:00 amRNSAppointment of Joint Broker
5th Jul 20177:00 amRNSTrading Update
3rd Jul 20177:00 amRNSSignificant New Clareti Contract Win
13th Jun 20177:00 amRNSExercise of Options & TVR
9th May 20174:39 pmRNSHolding(s) in Company
4th May 201712:51 pmRNSResult of AGM
4th May 20177:00 amRNSAGM Statement
11th Apr 20177:00 amRNSDirectorate Change
30th Mar 20179:11 amRNSReal-time analytics added to the Clareti platform
28th Mar 20173:57 pmRNSNotice of AGM
27th Mar 20177:00 amRNSIssue of Equity
14th Mar 20177:00 amRNSFinal Results
2nd Mar 20177:00 amRNSNotice of Results and Results Presentations
9th Jan 20177:00 amRNSTrading Update
6th Jan 201711:47 amRNSHolding(s) in Company
28th Dec 20169:23 amRNSFirst US Tier 1 Bank Contract Win for CTC
15th Dec 20167:00 amRNSContract Win for Clareti Transaction Control
9th Dec 20164:06 pmRNSIssue of Equity
21st Nov 20168:24 amRNSChange of Name
17th Nov 201611:27 amRNSResult of General Meeting
11th Nov 20162:34 pmRNSHolding(s) in Company
1st Nov 20165:56 pmRNSHolding(s) in Company
21st Oct 20163:43 pmRNSProposal for Change of Name
12th Oct 20164:12 pmRNSHolding(s) in Company
10th Oct 20167:00 amRNSCompletion of Acquisition
5th Oct 20167:00 amRNSCapital Markets Day
4th Oct 20169:15 amRNSResult of Placing
4th Oct 20167:05 amRNSProposed Placing
4th Oct 20167:00 amRNSAcquisition of C24 Technologies Ltd
31st Aug 20165:56 pmRNSDirectors' Dealings
26th Aug 20161:59 pmRNSHolding(s) in Company
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
25th Aug 20161:30 pmRNSDirector/PDMR Shareholding
24th Aug 20167:01 amRNSBoard Changes
24th Aug 20167:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.